TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Short Term Loans and Advances | ₹32 Cr | ₹18 Cr | ₹14 Cr | ₹1.79 Cr |
What is the latest Short Term Loans and Advances ratio of TRIDENT LIFELINE ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹1.79 Cr |
How is Short Term Loans and Advances of TRIDENT LIFELINE Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | 77.99 | |
| Mar2024 | ₹18 Cr | 29.50 | |
| Mar2023 | ₹14 Cr | 668.27 | |
| Mar2022 | ₹1.79 Cr | - | |
Compare Short Term Loans and Advances of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹482.7 Cr | 8.3% | 33% | 27% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 8.3% |
33% |
27% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses